Skip to main content

Freenome, Inc.

FRNM
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0002017526

No open-market purchases or sales by Freenome, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $95.7M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Freenome, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of FRNM: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders3234+2
Shares7.99M8.46M+474.5K (+5.9%)
Value$80.0M$86.1M+$6.12M (+7.7%)

New holders (6)

Institutions that held Freenome, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to FRNM in Q4 2024
InstitutionSharesValue% of portfolio
Rivernorth Capital Management, LLC331,540$3.38M0.16%
Decagon Asset Management LLP300,000$3.05M1.39%
Toronto Dominion Bank164,800$1.68M0.00%
DLD Asset Management, LP89,100$907.0K0.16%
Gritstone Asset Management LLC73,899$752.3K0.80%
Bulldog Investors, LLP50,000$509.0K0.13%

Sold out (4)

Institutions that held Freenome, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of FRNM in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Walleye Capital LLC183,488$1.84M
Walleye Trading LLC103,212$1.04M
Cowen and Company, LLC100,000$1.00M
Seven Grand Managers, LLC50,000$501.0K